Prevision di TG Therapeutics (TGTX)
Previson AI: TGTX
L'AI e publiche un prezi obietîf pal prossim dì di trading, pe fin de setemane e pe fin dal mês. La variazion e ven mesurade dal ultin prezi. Chestis a son stimis statistichis, no conseis di investiment.
Presi tai ultins 6 mês
Premium al mostre i obietîfs di presis de AI par 1 dì, 1 setemane e 1 mês par cheste e par ogni altre azion.
Vierç Premium🔒 Storic des previsions
Il storic des previsions — ogni prevision passade a fianç dal cjiusurament efetîf — al è part di Premium.
Vierç PremiumSu cheste societât
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.
